SCHEMBL3456001

SCHEMBL3456001

CCCCCCCCn1cc(-c2cnc(N)nc2-c2ccco2)ccc1=O

nearest known ligand 0.70

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 10/20 0.70
ADORA2B P29275 5/20 0.70
ADORA1 P30542 4/20 0.70
ADORA3 P0DMS8 3/20 0.45
PDE4B Q07343 1/20 0.40
CNR2 P34972 3/20 0.38
CNR1 P21554 1/20 0.38
HDAC1 Q13547 4/20 0.37
TLR8 Q9NR97 2/20 0.36
ICMT O60725 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1554287 0.96 ADORA2A (0.72) ADORA2AADORA2BADORA1ADORA3PDE4B
SCHEMBL1553621 0.92 ADORA2A (0.75) ADORA2AADORA2BADORA1ADORA3
SCHEMBL3456040 0.90 ADORA2A (0.67) ADORA2AADORA2BADORA1ADORA3HDAC1
SCHEMBL3455569 0.88 ADORA2A (0.69) ADORA2AADORA2BADORA1ADORA3HDAC1
SCHEMBL3455260 0.88 ADORA2A (0.69) ADORA2AADORA2BADORA1ADORA3HDAC1
SCHEMBL1553977 0.88 ADORA2A (0.74) ADORA2AADORA2BADORA1ADORA3
SCHEMBL1553479 0.86 ADORA2A (0.72) ADORA2AADORA2BADORA1ADORA3
SCHEMBL3456329 0.86 ADORA2A (0.72) ADORA2AADORA2BADORA1ADORA3
SCHEMBL3457193 0.86 ADORA2A (0.66) ADORA2AADORA2BADORA1ADORA3HDAC1
SCHEMBL1553964 0.85 ADORA2A (0.71) ADORA2AADORA2BADORA1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7396836-B2 Pyrimidine compound and medicinal composition thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-07-08 US claimed
EP-2246344-A1 Pyrimidine compounds and medicinal composition thereof Eisai R&D Management Co., Ltd. (JP) 2010-11-03 EP disclosed
US-20090030023-A1 PYRIMIDINE COMPOUNDS AND MEDICINAL COMPOSITION THEREOF HARADA HITOSHI 2009-01-29 US disclosed
US-20090030023-A1 PYRIMIDINE COMPOUNDS AND MEDICINAL COMPOSITION THEREOF HARADA HITOSHI 2009-01-29 US disclosed
US-20090030023-A1 PYRIMIDINE COMPOUNDS AND MEDICINAL COMPOSITION THEREOF HARADA HITOSHI 2009-01-29 US disclosed
US-7396836-B2 Pyrimidine compound and medicinal composition thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-07-08 US disclosed
US-7396836-B2 Pyrimidine compound and medicinal composition thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-07-08 US disclosed
US-7396836-B2 Pyrimidine compound and medicinal composition thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-07-08 US disclosed
US-20050004149-A1 Pyrimidine compound and medicinal composition thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-01-06 US disclosed
EP-1439175-A1 PYRIMIDINE COMPOUND AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-07-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090030023-A1 PYRIMIDINE COMPOUNDS AND MEDICINAL COMPOSITION THEREOF CBR3, AHR, HCCS ADORA2A 539/4885ADORA2B 307/4885ADORA1 328/4885
US-20050004149-A1 Pyrimidine compound and medicinal composition thereof ADORA2B, ADORA2A, ADORA3 ADORA2A 2/4885ADORA2B 1/4885ADORA1 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.